A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: Incidence of delayed cerebral ischemia and mortality

Neurological Research

Volumn 30, Issue 9, 2008, Pages 893-897

  Kerz, Thomas ^a   Victor, Anja ^a   Beyer, Christian ^a   Trapp, Inka ^a   Heid, Florian ^a   Reisch, Robert ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Delayed cerebral ischemia; Magnesium; Mortality; Statin; Subarachnoid hemorrhage

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM OXIDE; MAGNESIUM SULFATE; MAGNETRANS; MAGNEVEN; SIMVAHEXAL; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEATH; DELAYED CEREBRAL ISCHEMIA; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTICHOLESTEREMIC AGENTS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIMVASTATIN; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 57349138312     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313208X338034     Document Type: Article

References (16)

1. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627-1632
2. Tseng MY, Hutchinson PJ, Czosnyka M, et al. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 1545-1550
3. Stippler M, Crago E, Levy EI, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105: 723-729
4. Schmid-Elsaesser R, Kunz M, Zausinger S, et al. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: A randomized study. Neurosurgery 2006; 58: 1054-1065
5. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: A comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003; 98: 319-325
6. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14-20
7. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988; 68: 985-986
8. Jennett B, Teasdale G, Braakman R, et al. Predicting outcome in individual patients after severe head injury. Lancet 1976; 1: 1031-1034
9. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9
10. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36: 2024-2026
11. McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950-2956
12. Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 2004; 23: 501S-505S
13. Chakraborti S, Chakraborti T, Mandal M, et al. Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 2002; 238: 163-179
14. Kruger P, Fitzsimmons K, Cook D, et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006; 32: 75-79
15. Mortensen EM, Pugh MJ, Copeland LA, et al. Impact of statins and ace inhibitors on mortality for subjects hospitalized with pneumonia. Eur Respir J 2008; 31: 611-617
16. Dorhout Mees SM, van den Bergh WM, Algra A, et al. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2007; 78: 729-731